表紙
市場調査レポート

世界の医薬品包装産業(2011年)

Pharmaceutical Packaging Industry - 2011 Yearbook

発行 GBI Research 商品コード 224308
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
世界の医薬品包装産業(2011年) Pharmaceutical Packaging Industry - 2011 Yearbook
出版日: 2011年12月01日 ページ情報: 英文 76 Pages
概要

全世界の医薬品包装産業は、2010年には478億米ドルの規模に達しました。2010-2017年の年平均成長率は7.3%、2017年の市場規模は780億米ドルと予想されています。

当レポートでは、全世界の医薬品包装産業の最新動向について分析し、全体的な産業構造、市場促進・阻害要因や市場の主な動向、全世界および各国の規制体制、各地域・主要国の市場動向、主要企業のプロファイルと資本取引動向などの情報を取りまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 医薬品包装産業の概要

  • イントロダクション
    • 包装産業の主要な側面
  • 医薬品包装産業の分類
    • ブリスター包装
    • プラスチック瓶
    • ラベル・アクセサリー
    • 薬剤供給装置
    • パウチ・ストリップパック
    • キャップ・クロージャー
    • 二次容器
    • その他
  • 2010年の市場規模

第4章 市場促進・抑制要因と主な傾向

  • 市場促進要因
    • 成長中の偽造市場から利益を得る包装市場
    • 医薬品市場の成長に伴う、医薬品包装市場の成長
    • 遵守率改善のため必要とされる、包装産業の技術革新
    • 高齢化による医薬品市場の成長
    • 特許の障壁によるジェネリック市場の成長
  • 市場抑制要因
    • 複雑な規制による、医薬品産業の収益への影響
    • 衛生規制の改正の、医薬品包装産業に対する逆効果
    • 政治・規制・経済リスクに左右される、医薬品包装産業の海外展開
    • 包装産業における品質維持の困難性
    • 原材料の入手可能性・価格変動:医薬品包装企業にとっての問題
  • 主な傾向
    • 資源の大きな割合が偽造品対抗策に費やされる
    • 特定の病期のための革新的な包装の要求
    • ベビーブーム世代のための適切な包装
    • コンプライアンスが重要な要素である
    • 単位服用量の増大

第5章 規制体制

  • 医薬品包装の国際標準
    • PS 9000:2001−−医薬品包装素材
    • ISO 15378: 2006
  • 各国の医薬品包装向けガイドライン
    • 米国の規制体制
    • 欧州の規制体制
    • アジア太平洋地域の規制体制

第6章 地域別市場動向

  • 地域分類
  • 地域別動向
    • アジア太平洋地域の医薬品包装産業は米国・欧州よりも早い速度で成長
    • 新興市場国の包装産業は先進国ほどは早く成長せず
  • 新興市場国
    • 中国
    • インド
    • ブラジル
    • ロシア

第7章 競争環境:事業内容・財務業績・近年の発展

  • Rexam
  • Schott
  • Nypro
  • Consort Medical
  • Becton Dickinson (BD)
  • Gerresheimer
  • West Pharmaceutical Services
  • Amcor
  • Ypsomed
  • Bormiolli Rocco
  • Duran
  • Catalent
  • MeadWestvaco

第8章 戦略的企業統合

  • 概要
  • Consort Medicalによる The Medical House (TMH)の買収
  • BDによるHandylabおよびAccuri Cytometersの買収
  • GerresheimerによるVedatの買収
  • AmcorによるAlcan Pharma Plastics PackagingおよびBall Plastics Packaging Americasの買収

第9章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Summary

GBI Research, the leading business intelligence provider, has released its latest research “Pharmaceutical Packaging Industry - 2011 Yearbook” which provides insights into the global pharmaceutical packaging market and information on market forecasts until 2017. In addition to this, the geographical distribution of pharmaceutical packaging manufacturers across emerging BRIC nations (Brazil, Russia, India and China) is also detailed in the report. Key cost and developmental issues are also addressed. The report provides analysis on the competitive landscape, including the benchmarking of top companies. Finally, key trends analysis on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging is detailed.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

GBI Research estimates that the global pharmaceutical packaging market was worth $47.8 billion in 2010. The market is forecast to grow at a CAGR of 7.3% from 2010-2017. The global pharmaceutical industry is currently recording rapid expansion, with advances in manufacturing processes, technology innovation and integration. Growth is likely to be high in emerging economies such as India and China, primarily on account of increasing generics and contract manufacturing activities.

GBI Research found that the fastest growing segment in the pharmaceutical packaging market is prefillable syringes and parenteral vials. This segment will continue to expand due to advances in biotechnology which will result in the introduction of new therapies that must be injected. The increasing demand for biologics will increase demand for innovative product packaging solutions in the global pharmaceutical packaging market. Also, with more than $142 billion worth of drugs going off-patent in the next five years, generic drug manufacturers will emerge as a major segment driving demand for pharmaceutical packaging.

Scope

  • Detailed market characterization, including market size, technology adoption and forecasts until 2017.
  • Data and analysis on the global pharmaceutical packaging market in the emerging BRIC nations.
  • Analysis and review of the key events and milestones that will impact the future of the global pharmaceutical packaging market. Each trend is independently researched to provide qualitative analysis of its implications.
  • Insightful review of key industry drivers, restraints and challenges which are likely to impact the global pharmaceutical packaging market in the long run.
  • The report also covers information on the leading market companies and the competitive landscape. Key companies covered include: Schott AG, Gerresheimer AG, Duran Group, Nypro Inc., Rexam PLC and Becton Dickinson (BD).

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global pharmaceutical packaging market.
  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the pharmaceutical packaging market in the future.
  • Formulate effective sales and marketing strategies through understanding of the competitive landscape and through analysis of the performance of various competitors.
  • Identify emerging companies with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidations, investments and strategic partnerships.
  • What's the next big thing in the global pharmaceutical packaging market landscape? - Identify, understand and capitalize.

Executive Summary

GBI Research's new report, “Pharmaceutical Packaging Industry - 2011 Yearbook”, provides insights into the global pharmaceutical packaging market, with coverage of the market landscape, key market trends, market drivers and restraints. The report provides market forecasts for the global pharmaceutical packaging industry until 2017. The geographical distribution of pharmaceutical packaging manufacturers across key geographies, such as the US, the top five countries in the European region, Japan and BRIC (Brazil, Russia, India and China) countries are also provided. Key cost and developmental issues are also addressed. The report provides an in-depth analysis of the competitive landscape, including the benchmarking of top companies, key trends on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging.

Global Pharmaceutical Packaging Industry to Record Growth with Rapid Expansion in the Global Pharmaceutical Industry

The global pharmaceutical packaging market was valued at $47.8 billion in 2010. The market is forecast to grow at a compound annual growth rate (CAGR) of 7.3% from 2010-2017, to reach a value of $78 billion by 2017. The global pharmaceutical industry is currently registering rapid expansion, with advances in manufacturing processes, and technology innovation and integration, which are the main factors behind the growth of the pharmaceutical packaging industry globally. This growth is expected to be highest in the emerging economies of India and China, primarily on account of increasing generics and contract manufacturing activities in these countries.

Pharmaceutical Packaging Industry Will Overcome Challenges to Record High Growth Rates in the Future

The pharmaceutical packaging industry will continue to grow as drugs worth $142 billion go off-patent in the next five years, expanding the generic market and the entire pharmaceutical packaging industry. The fastest growth in the pharmaceutical packaging market is expected to come from prefillable syringes and parenteral vials, which will continue to expand as advances in biotechnology lead to the introduction of new therapies that must be injected. The increasing demand for biologics will strengthen demand for innovative product packaging solutions in the global pharmaceutical packaging market.

All of these factors, along with the growing pharmaceutical industry, will continue to drive demand for packaging. However, the packaging industry will have to overcome challenges, such as the availability and price volatility of raw materials and changing health regulations, in order to meet increasing demand from the growing pharmaceutical industry.

Increasing Demand for Drug Delivery Devices and Blister Packaging Will Strengthen the Growth of the Pharmaceutical Packaging Industry

Plastic bottles emerged as the largest revenue generating segment for the pharmaceutical packaging industry in 2010, recording annual revenues of approximately $9.5 billion. This was closely followed by blister packaging and drug delivery devices, which generated revenues of $8.1 billion and $6.6 billion, respectively, in 2010. Other important segments in the pharmaceutical packaging industry were labels, accessories and other containers.

The market size of drug delivery devices and blister packaging is expected to grow at a faster rate than other segments in the pharmaceutical packaging industry. Increasing demand for improved drug delivery mechanisms and more complex biologic molecules will have to be complimented with better drug delivery devices. Products such as inhalers, nasal sprays, transdermal patches and oral ingestion containers have redefined the market and become as important as the drug itself. Also, blister packaging will record growth because of increasing usage of unit dose packaging. Some industry segments such as plastic bottles will register average growth, while others, such as glass bottles and containers, may record a decline in demand as they will be replaced by lightweight and cheap plastic products.

Developing Nations to Take Advantage of Increasing Demand for Pharmaceutical Packaging

The global pharmaceutical packaging market is dominated by the US, with a market share of 37% in 2010. This was followed by Western Europe and Asia Pacific, with market shares of 33% and 30%, respectively, in 2010. However, this trend is likely to change in the future as Asia Pacific is poised to grow faster than Europe and the US. Over the next five years, the Asia Pacific market is expected to grow by more than 10%, while Western European and the US markets will grow at 6% and 4%, respectively.

Increasing drug manufacturing activities in emerging nations is driving demand for packaging in countries such as India and China. These countries have emerged as favorite destinations for packaging companies, primarily due to lower wages, a skilled and plentiful workforce and the increasing availability of state-of-the-art technology. Also, demand for pharmaceutical packaging in these countries has increased, particularly in the wake of patent expiries, which allow these countries to emerge as centers for generic drug manufacturing.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Pharmaceutical Packaging Industry - Introduction

  • 2.1. GBI Research Report Guidance

3. Pharmaceutical Packaging Industry - Overview

  • 3.1. Introduction
    • 3.1.1. Key Aspects of Packaging
  • 3.2. Industry Segments in Pharmaceutical Packaging
    • 3.2.1. Blister Packaging
    • 3.2.2. Plastic Bottles
    • 3.2.3. Labels and Accessories
    • 3.2.4. Drug Delivery Devices
    • 3.2.5. Pouches and Strip Packs
    • 3.2.6. Caps and Closures
    • 3.2.7. Secondary Containers
    • 3.2.8. Others
  • 3.3. Market Size in 2010

4. Pharmaceutical Packaging Industry - Market Drivers, Barriers and Key Trends

  • 4.1. Drivers
    • 4.1.1. Packaging Market Will Capitalize on the Growing Counterfeit Market
    • 4.1.2. Growing Pharmaceutical Market Will Lead to Growth in the Pharmaceutical Packaging Market
    • 4.1.3. Innovation in Packaging Industry is Required to Improve the Compliance Rate
    • 4.1.4. Aging Population Will Lead to Growth in the Pharmaceutical Market
    • 4.1.5. Patent Cliff Will Strengthen the Generic Market
  • 4.2. Barriers
    • 4.2.1. Complex Pharmaceutical Industry Regulations Influence Packaging Industry Revenues
    • 4.2.2. Changes in Health Regulations Adversely Affect the Pharmaceutical Packaging Industry
    • 4.2.3. Global Operations for Pharmaceutical Packaging are Subject to Political, Regulatory and Economic Risks
    • 4.2.4. Consistent Quality is a Challenge for the Packaging Industry
    • 4.2.5. The Availability and Price Volatility of Raw Materials is a Problem for Pharmaceutical Packaging Companies
  • 4.3. Key Trends
    • 4.3.1. Greater Proportion of Resources Spent on Anti-Counterfeiting Measures
    • 4.3.2. Innovative Packaging Requirements for Specific Disorders
    • 4.3.3. The Right Package for Baby Boomers
    • 4.3.4. Compliance is a Key Factor
    • 4.3.5. The Rise of Unit Dosing

5. Pharmaceutical Packaging Industry - Regulatory Framework

  • 5.1. International Standards for Pharmaceutical Packaging
    • 5.1.1. PS 9000:2001 - Pharmaceutical Packaging Materials
    • 5.1.2. ISO 15378: 2006
  • 5.2. National Guidelines for Pharmaceutical Packaging
    • 5.2.1. Regulatory Framework in the US
    • 5.2.2. Regulatory Framework in Europe
    • 5.2.3. Regulatory Framework in Asia Pacific

6. Pharmaceutical Packaging Industry - Geographical Landscape

  • 6.1. Geographical Split
  • 6.2. Geographical Trends
    • 6.2.1. Pharmaceutical Packaging in the APAC Region will Grow Faster than the US and Europe
    • 6.2.2. Packaging Industry Growth in Emerging Nations Will be Faster than in Developed Nations
  • 6.3. Emerging Markets
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Brazil
    • 6.3.4. Russia

7. Pharmaceutical Packaging Industry - Competitive Landscape

  • 7.1. Rexam
    • 7.1.1. Business Description
    • 7.1.2. Financial Performance
    • 7.1.3. Recent Development
  • 7.2. Schott
    • 7.2.1. Business Description
    • 7.2.2. Financial Performance
    • 7.2.3. Recent Development
  • 7.3. Nypro
    • 7.3.1. Business Description
    • 7.3.2. Financial Performance
    • 7.3.3. Recent Development
  • 7.4. Consort Medical
    • 7.4.1. Business Description
    • 7.4.2. Financial Performance
    • 7.4.3. Recent Developments
  • 7.5. Becton Dickinson (BD)
    • 7.5.1. Business Description
    • 7.5.2. Financial Performance
    • 7.5.3. Recent Developments
  • 7.6. Gerresheimer
    • 7.6.1. Business Description
    • 7.6.2. Financial Performance
    • 7.6.3. Recent Developments
  • 7.7. West Pharmaceutical Services
    • 7.7.1. Business Description
    • 7.7.2. Recent Developments
  • 7.8. Amcor
    • 7.8.1. Business Description
    • 7.8.2. Financial Performance
    • 7.8.3. Recent Developments
  • 7.9. Ypsomed
    • 7.9.1. Business Description
    • 7.9.2. Financial Performance
    • 7.9.3. Recent Development
  • 7.10. Bormiolli Rocco
    • 7.10.1. Business Description
    • 7.10.2. Recent Development
  • 7.11. Duran
    • 7.11.1. Business Description
    • 7.11.2. Recent Developments
  • 7.12. Catalent
    • 7.12.1. Business Description
    • 7.12.2. Financial Performance
    • 7.12.3. Recent Developments
  • 7.13. MeadWestvaco
    • 7.13.1. Business Description
    • 7.13.2. Financial performance
    • 7.13.3. Recent Developments

8. Pharmaceutical Packaging Industry - Strategic Consolidations

  • 8.1. Overview
  • 8.2. Consort Medical Acquires The Medical House (TMH)
  • 8.3. BD Acquires Handylab and Accuri Cytometers
  • 8.4. Gerresheimer Acquires Vedat
  • 8.5. Amcor Acquires Alcan Pharma Plastics Packaging and Ball Plastics Packaging Americas

9. Pharmaceutical Packaging Industry - Appendix

  • 9.1. Market Definitions
  • 9.2. Abbreviations
  • 9.3. Research Methodology
    • 9.3.1. Coverage
    • 9.3.2. Secondary Research
    • 9.3.3. Primary Research
    • 9.3.4. Expert Panel Validation
  • 9.4. Section-wise Methodology
    • 9.4.1. Trends, Market Barriers and Drivers in the Pharmaceutical Packaging Industry
    • 9.4.2. The Regulatory Framework of Pharmaceutical Packaging Industry
    • 9.4.3. Geographical Landscape
    • 9.4.4. Company Profiling
    • 9.4.5. Strategic Consolidations
  • 9.5. Contact Us
  • 9.6. Disclaimer
  • 9.7. Sources

List of Tables

  • Table 1: Pharmaceutical Packaging Market, Global, Revenue Forecasts ($m), 2010-2017
  • Table 2: Pharmaceutical Packaging Industry, Regulatory Guidelines, Asia-Pacific, 2010

List of Figures

  • Figure 1: Pharmaceutical Packaging Market, Typical Pharmaceutical Packaging Layout
  • Figure 2: Pharmaceutical Packaging Market, Key Aspects of Packaging
  • Figure 3: Pharmaceutical Packaging Market, Segments in Pharmaceutical Packaging
  • Figure 4: Pharmaceutical Packaging Market, Global, Revenue Forecasts, 2010-2017
  • Figure 5: Pharmaceutical Packaging Market, Global, Market Share by Industry Segments, 2010
  • Figure 6: Pharmaceutical Packaging Industry, Global, Growth Rates by Segments, 2011
  • Figure 7: Pharmaceutical Packaging Market, Global, Market Drivers and Barriers, 2011
  • Figure 8: Pharmaceutical Packaging Market, Anti-Counterfeit Measures, Impact Analysis, 2010
  • Figure 9: Pharmaceutical Packaging Market, Growth of Pharmaceutical Market-Impact Analysis, 2010
  • Figure 10: Pharmaceutical Packaging Market, Innovation in Packaging Industry-Impact Analysis, 2010
  • Figure 11: Pharmaceutical Packaging Market, Aging Population-Impact Analysis, 2010
  • Figure 12: Pharmaceutical Packaging Market, Patent Cliff, Impact Analysis, 2010
  • Figure 13: Pharmaceutical Packaging Market, Regulations of the Pharmaceutical Industry, Impact Analysis, 2010
  • Figure 14: Pharmaceutical Packaging Market, Changes in the Regulations of the Pharmaceutical Industry, Impact Analysis, 2010
  • Figure 15: Pharmaceutical Packaging Market, Political, Regulatory and Economic Risks, Impact Analysis, 2010
  • Figure 16: Pharmaceutical Packaging Market, Producing Consistent Quality, Impact Analysis, 2010
  • Figure 17: Pharmaceutical Packaging Market, Availability and Price Volatility of Raw Materials, Impact Analysis, 2010
  • Figure 18: Pharmaceutical Packaging Industry, Key Trends, 2010
  • Figure 19: Pharmaceutical Packaging Industry, Guidance on PS 9000 GMP Clauses, 2010
  • Figure 20: Pharmaceutical Packaging Industry, ISO 15278, Key Aspects, 2010
  • Figure 21: Pharmaceutical Packaging Industry, Regulations Governing Packaging of Pharmaceuticals, 2010
  • Figure 22: Pharmaceutical Packaging Industry, Geographical Split by Percentage, 2010
  • Figure 23: Pharmaceutical Packaging Industry, Regional Growth Forecast, 2010
  • Figure 24: Pharmaceutical Packaging Industry, China - Porter's Diamond of Comparative Advantage, 2010
  • Figure 25: Pharmaceutical Packaging Industry, India - Porter's Diamond of Comparative Advantage, 2010
  • Figure 26: Pharmaceutical Packaging Industry, Brazil - Porter's Diamond of Comparative Advantage, 2010
  • Figure 27: Pharmaceutical Packaging Industry, Russia - Porter's Diamond of Comparative Advantage, 2010
  • Figure 28: Pharmaceutical Packaging Industry, Rexam-Snapshot, 2010
  • Figure 29: Pharmaceutical Packaging Industry, Rexam-Geographical Presence, 2010
  • Figure 30: Pharmaceutical Packaging Industry, Schott-Company Profile, 2010
  • Figure 31: Pharmaceutical Packaging Industry, Schott-Geographical Presence, 2010
  • Figure 32: Pharmaceutical Packaging Industry, Nypro-Snapshot, 2010
  • Figure 33: Pharmaceutical Packaging Industry, Nypro-Geographical Presence, 2010
  • Figure 34: Pharmaceutical Packaging Industry, Consort Medical-Company Overview, 2010
  • Figure 35: Pharmaceutical Packaging Industry, Consort Medical-Geographical Presence, 2010
  • Figure 36: Pharmaceutical Packaging Industry, Becton Dickinson-Company Overview, 2010
  • Figure 37: Pharmaceutical Packaging Industry, Becton Dickinson-Geographical Presence, 2010
  • Figure 38: Pharmaceutical Packaging Industry, Gerresheimer-Company Overview, 2010
  • Figure 39: Pharmaceutical Packaging Industry, Gerresheimer-Geographical Presence, 2010
  • Figure 40: Pharmaceutical Packaging Industry, West Pharmaceutical Services-Company Overview, 2010
  • Figure 41: Pharmaceutical Packaging Industry, West Pharmaceutical Services-Geographical Presence, 2010
  • Figure 42: Pharmaceutical Packaging Industry, Amcor-Company Overview, 2010
  • Figure 43: Pharmaceutical Packaging Industry, Amcor-Geographical Presence, 2010
  • Figure 44: Pharmaceutical Packaging Industry, Ypsomed-Company Overview, 2010
  • Figure 45: Pharmaceutical Packaging Industry, Ypsomed-Geographical Presence, 2010
  • Figure 46: Pharmaceutical Packaging Industry, Bormioli Rocco-Company Overview, 2010
  • Figure 47: Pharmaceutical Packaging Industry, Bormioli Rocco-Geographical Presence, 2010
  • Figure 48: Pharmaceutical Packaging Industry, Duran-Company Overview, 2010
  • Figure 49: Pharmaceutical Packaging Industry, Duran-Geographical Presence, 2010
  • Figure 50: Pharmaceutical Packaging Industry, Catalent-Company Overview, 2010.
  • Figure 51: Pharmaceutical Packaging Industry, Catalent-Geographical Presence, 2010
  • Figure 52: Pharmaceutical Packaging Industry, MeadWestvaco-Company Overview, 2010
  • Figure 53: Pharmaceutical Packaging Industry, MeadWestvaco-Geographical Presence, 2010.
Back to Top